receive daily
reports of the
TOP PICKS
OR
your personal
stock choices
| Click Here to receive daily reports of the TOP PICKS OR your personal stock choices | STOCKCHASEWhat the experts are saying! |
|
| There are 2 registered members and 74 guests viewing the site. | Follow us on Twitter |  Rss Top Picks Feed | Rss Daily Feed |
|
| Comment | 120.640 | John Hood | Nasdaq BioTech ETF. Certainly looks like it is breaking out. About 60% Biotech and 40% Pharma. Would have no problem going into this sector. Ilways a little concerned about going into something like this with US’s but with the Cdn$ doing so well, it might not be a problem. | 2012-02-03 | |
| PAST TOP PICK | 94.090 | Don Vialoux | (A Top Pick June 30/11. Down 11.5%.) Started doing okay but then the seasonal trade started to go against him so he got out. | 2011-10-07 | |
| TOP PICK | 106.660 | Don Vialoux | Nasdaq Biotechnology ETF, which has a seasonal strength from June 23 two the 2nd week of September. This is because of a series of healthcare conferences that happen at this time of year. | 2011-06-30 | |
| PAST TOP PICK | 82.530 | Vinny Catalano | (A Top Pick Jan 2/09. Up 14.8%.) | 2009-09-22 | |
| TOP PICK | 72.070 | Vinny Catalano | Big pharma is running out of patents and they need to find a way to grow. Biotech is the area in which development is taking place with products being created. Valuation is reasonably good. | 2009-01-02 | |
| TOP PICK | 77.250 | Vinny Catalano | Really good valuation at under 16X PE. Large diversification. This gives you a play into the area of pharmaceutical. Big pharma is running out of pipeline and the companies in the biotech space are very attractive acquisition candidates. | 2008-06-10 | |
| TOP PICK | 75.400 | Don Vialoux | This gives you a basket of biotech stocks which gives diversification. In the healthcare sector, the biggest areas of growth seem to be in the biotech area. | 2004-05-14 | |
| TOP PICK | 76.900 | Peter Brieger | At a good price. Likes the biotech sector. Volatile. | 2002-02-15 | |
| TOP PICK | 88.900 | Peter Brieger | Gives exposure to 75 US biotech stocks. Buy for a 2/3 year hold. Low MER. | 2001-11-14 |
